Blood test could predict brain inflammation relapses in kids

NCT ID NCT06863974

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study aims to find blood-based biomarkers that can predict whether a child with acute disseminated encephalomyelitis (ADEM) will experience relapses. Researchers will analyze immune cells from blood samples of 20 children aged 1-18 with a first demyelinating event. The goal is to identify molecular or cellular signatures that indicate a higher risk of recurrence, enabling earlier use of disease-modifying therapies to prevent long-term disability.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this could help doctors predict which children with ADEM will have relapses, allowing earlier treatment to prevent long-term damage.
What could go wrong
This is a small, early observational study with only 20 participants, so findings may not apply to all patients. It looks for patterns in blood, not a treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE DISSEMINATED ENCEPHALOMYELITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • CHU Montpellier

    NOT_YET_RECRUITING

    Montpellier, 34295, France

  • CHU d'Angers

    RECRUITING

    Angers, 49240, France

  • Hôpital Necker Enfants Malades

    NOT_YET_RECRUITING

    Paris, 75015, France

  • Univesity Hostipal of APHP

    RECRUITING

    Le Kremlin-Bicêtre, 94270, France

  • Univesity Hostipal of Brest

    RECRUITING

    Brest, 29200, France

  • Univesity Hostipal of Nantes

    RECRUITING

    Nantes, 44093, France

  • Univesity Hostipal of Rennes

    RECRUITING

    Rennes, 35000, France

  • Univesity Hostipal of Tours

    RECRUITING

    Tours, 37000, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.